Plains Venture PartnersPlains Venture PartnersPlains Venture PartnersPlains Venture Partners
  • About
  • Portfolio
  • Team
  • Investor Login

OMRF researchers have identified a compound that has been successfully shown to decrease both tumor size and tumor vasculature in animal models of Glioblastoma Multiforme (GBM), an aggressive type of malignant brain tumor.

Year Founded: 2012

Year Partnered: 2012

Category: Biotech/Pharma

Fund: Oklahoma Seed Capital Fund  

Acquired in 2016 by Oblato, Inc.

  • Disclaimer & Disclosure

Oklahoma City Location

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305

Tulsa Location

100 S Cincinnati Ave, 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592

  • Disclaimer & Disclosure
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Portfolio
  • Team
  • Funds
  • Investor Login
Plains Venture Partners